medicine-technology-1/online-h1n1-management-3a-fairchoice-helps-schools-respond-to-infectious-disease-on-campus-4806-2/;msg90356

Breaking Biology Technology:Martek Signs Sole-Source Supply Agreement with Fonterra 2 Martek Signs Sole-Source Supply Agreement with Fonterra 3 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5 Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2 Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3 Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2 Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3

[0] Martek Signs Sole-Source Supply Agreement with Fonterra [0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES [0] Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years [0] Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner

Breaking Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2 Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3 Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4 GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2 GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3 GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4 GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5 GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6 Ancient penguin DNA raises doubts about accuracy of genetic dating techniques 10679 1 Ancient penguin DNA raises doubts about accuracy of genetic dating techniques 10679 2 In the war between the sexes the one with the closest fungal relationship wins 10677 1 In the war between the sexes the one with the closest fungal relationship wins 10677 2 Survey Reveals Big Gap in Understanding of Depression 3B Almost 50 Percent of Caregivers Have Also Been Diagnosed 61088 1 Survey Reveals Big Gap in Understanding of Depression 3B Almost 50 Percent of Caregivers Have Also Been Diagnosed 61088 2 Survey Reveals Big Gap in Understanding of Depression 3B Almost 50 Percent of Caregivers Have Also Been Diagnosed 61088 3 Survey Reveals Big Gap in Understanding of Depression 3B Almost 50 Percent of Caregivers Have Also Been Diagnosed 61088 4

[0] InterMune to Present at Deutsche Bank Biotech Confab [0] Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes [0] GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer